Skip to content

LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA Implant

LISA Post Market Clinical Follow-Up Study:Post Marketing Prospective Documentation of Clinical Outcomes (Post-operative, Safety and Performance) After Lumbar Dynamic Stabilization Surgery With LISA Implant

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04631133
Acronym
LISA-PMCF
Enrollment
136
Registered
2020-11-17
Start date
2019-04-17
Completion date
2028-12-31
Last updated
2022-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain, Degenerative Disc Disease, Herniated Disc, Lumbar Canal Stenosis

Keywords

Chronic Low-back Pain, Herniated Disc, Degenerative Disc Disease, Lumbar Canal Stenosis, Dynamic Stabilization Implants, Post-Market Clinical Follow-Up Study

Brief summary

The study is a post-market surveillance study of the Lumbar Implant for Stiffness Augmentation (LISA), a medical device, which is used to treat low-back pain that accompanies degenerative lesions of grades II, III, and IV (Pfirrmann MRI classification). Post-market means the device (i.e. the LISA implant) being used in this study has already obtained CE certification and is commercially available for use in the European market. The LISA device consists of 3 components: A PEEK interspinous spacer, a polyester band, and a titanium blocker. The spacer is positioned between two adjacent spinous processes, the band is belted around the spinous processes and through the spacer, and the blocker is used to lock the band inside the spacer. Medical Device manufacturers conduct post-market clinical studies in order to continuously evaluate the product scientifically and to comply with legal and ethical obligations. With these studies, the long-term safety as well as performance of their medical devices are assessed. This study, which is initiated and sponsored by BACKBONE (LISA designer, developer, manufacturer and marketer), aims to evaluate the long-term safety and performance of the LISA implant for the treatment of lumbar degenerative disease and to evaluate the treatment.

Interventions

DEVICELumbar Implant for Stiffness Augmentation (LISA)

The LISA Posterior Dynamic Stabilization System is intended to treat low-back pain that accompanies degenerative lesions of grade II, III and IV (Pfirrmann MRI classification).

Sponsors

BACKBONE
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Skeletally mature patients Patient ≥18 years of age * Patients with low-back pain caused by degenerative lesions of grade II, III and IV (Pfirrmann MRI classification) * Failed conservative treatment for low back pain conducted for at least 6 months

Exclusion criteria

* Stage V degenerative disk lesions in Pfirrmann's MRI classification * Spondylolisthesis * Osteoporosis * Non-specific back pain * Modic 2 and Modic 3 changes * L5/S1 segments affected * Local or general infections that may compromise the surgical goals * Major local inflammatory phenomena * Pregnant and lactating Women * Immunosuppressive diseases * Bone immaturity * Severe mental illnesses * Bone metabolism diseases that may compromise the mechanical support expected from this type of implant * Patient with worker's compensation, under litigation or on disability benefits * Excessive physical activities * Patients deprived of their liberty in accordance with respective national regulations * Protected patients or patients not in a position to declare his or her consent in accordance with respective national regulations

Design outcomes

Primary

MeasureTime frame
LISA implant survival rate 2 years after surgery defined as successful LISA implantation without reoperation, revision, or removal/ ODI change between pre-operative assessment and 2 years follow-up (FU)/ 1ary endpoint will also be evaluated at 1-year FU24-months post surgery; 12-months post surgery

Secondary

MeasureTime frameDescription
Duration of the surgeryPerioperative
Duration of the implant placementPerioperative
Amount of blood lossPerioperative
Scoring of the surgical technique assessed by a 14-items questionPerioperative14 steps of the surgical technique are rated from 0 to 7; 0 being considered as very easy and 7 being considered as very difficult
Number of hospitalization days3-months post surgery
Time to return to normal activity (working) depending on the patient's profession (blue collar, white collar)3-months post surgery
Number of patients with reoperations/ revision or removal at the operative level or on adjacent levels relating to the device and not the pathology/ implant breakage (polyester band rupture)3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Number of patients with migration or rupture of any implant component (Polyester band loose)/ major unanticipated device related complications/ post-operative scapular pain/ recurrence of the initial symptoms/ degeneration of the adjacent segments3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Number of patients with superficial infection/ dural injury/ bone fracture or bone erosion anywhere implant is in contact with the anatomy/ Any other procedure or device related adverse events3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgery
Oswestry Disability Index (ODI) to assess limitations of various activities of daily living.Pre-operative
Change from baseline in Oswestry Disability Index at 3 months3-months post surgeryOswestry Disability Index (ODI) is used to assess limitations of various activities of daily living.
Change from baseline in Oswestry Disability Index at 6 months6-months post surgeryOswestry Disability Index (ODI) is used to assess limitations of various activities of daily living.
Change from baseline in Oswestry Disability Index at 48 months48-months post surgeryOswestry Disability Index (ODI) is used to assess limitations of various activities of daily living.
Change from baseline in Oswestry Disability Index at 72 months72-months post surgeryOswestry Disability Index (ODI) is used to assess limitations of various activities of daily living.
Visual Analogue Scale (VAS) to assess back painPre-operativePatients rate their back pain from 0 to 10, 0 meaning No pain at all and 10 meaning the worst pain ever possible
Change from baseline in Visual Analogue Scale (VAS) for back pain at 3 months3-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for back pain at 6 months6-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for back pain at 12 months12-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for back pain at 24 months24-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for back pain at 48 months48-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for back pain at 72 months72-months post surgery
Visual Analogue Scale (VAS) to assess right leg painPre-operativePatients rate their right leg pain from 0 to 10, 0 meaning No pain at all and 10 meaning the worst pain ever possible
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 3 months3-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 6 months6-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 12 months12-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 24 months24-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 48 months48-months post surgery
Change from baseline in Visual Analogue Scale (VAS) for right leg pain at 72 months72-months post surgery
Visual Analogue Scale (VAS) to assess left leg painPre-operativePatients rate their left leg pain from 0 to 10, 0 meaning No pain at all and 10 meaning the worst pain ever possible
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 3 months3-months post-surgery
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 6 months6-months post-surgery
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 12 months12-months post-surgery
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 24 months24-months post-surgery
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 48 months48-months post-surgery
Change from baseline in Visual Analogue Scale (VAS) for left leg pain at 72 months72-months post-surgery
Patient satisfaction with treatment assessed by a 4-items question3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgeryPatients rate their satisfaction with treatment choosing one of the following options: Very satisfied/Somewhat satisfied/Somewhat dissatisfied/Very Dissatisfied
Patient's recommendation for treatment assessed by a 4-items question3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgeryPatient rate wether they would recommend the same treatment to a friend with the same condition, choosing one of the following options: Definitely YES/Probably YES/ Probably NO/ Definitely NOT
Patient's opinion related to the treatment assessed by a 6-items question3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgeryPatient rate how effective was the treatment in eliminating the symptoms choosing one of the following options: very effective, relieved all the symptoms, moderately effective, somewhat effective, somewhat ineffective, moderately ineffective, very ineffective, did not relieve or lessen the symptoms
Surgeon surgery outcome assessed by a 4-items question3-months post surgery; 6-months post surgery; 12-months post surgery; 24-months post surgery; 48-months post surgery; 72-months post surgerySurgeons rate the result of the surgery, choosing one of the following options: Excellent; Good; Fair; Poor
Segmental joints condition assessed thanks to radiological results (if available)Pre-operative
Change from baseline in segmental joints condition at 3-months3-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Change from baseline in segmental joints condition at 6-months6-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Change from baseline in segmental joints condition at 12-months12-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Change from baseline in segmental joints condition at 24-months24-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Change from baseline in segmental joints condition at 48-months48-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Change from baseline in segmental joints condition at 72-months72-months post surgerySegmental joints condition are assessed thanks to radiological results (if available)
Narrowness of the spinal canal assessed thanks to radiological results (if available)Pre-operative
Change from baseline in narrowness of the spinal canal at 3 months3-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
Change from baseline in narrowness of the spinal canal at 6 months6-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
Change from baseline in narrowness of the spinal canal at 12 months12-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
Change from baseline in narrowness of the spinal canal at 24 months24-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
Change from baseline in narrowness of the spinal canal at 48 months48-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
Change from baseline in narrowness of the spinal canal at 72 months72-months post surgeryNarrowness of the spinal canal is assessed thanks to radiological results (if available)
LISA implant survival rate defined as successful LISA implantation without reoperation, revision, or removal3-months post surgery; 6-months post surgery; 48-months post surgery; 72-months post surgery
Change from baseline in foraminal compression at 3 months3-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Change from baseline in foraminal compression at 6 months6-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Change from baseline in foraminal compression at 12 months12-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Change from baseline in foraminal compression at 24 months24-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Change from baseline in foraminal compression at 48 months48-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Change from baseline in foraminal compression at 72 months72-months post-surgeryForaminal compression is assessed thanks to radiological results (if available)
Foraminal compression assessed thanks to radiological results (if available)Pre-operative

Countries

Denmark, France, Germany

Contacts

Primary ContactAurélie Affret
aat@backbone.pro0033686114973
Backup ContactNazanine Sahami
nsi@backbone.pro0033646592539

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026